Mapmygenome Launches Gynaecmap™ Personal Genomics Panel for Women
Hyderabad, India, March 8, 2014: Mapmygenome launched Gynaecmap™, a personal genomics panel exclusively for women, on International Women’s Day, March 8, 2014.
As an introductory offer, Gynaecmap™ will be available at a 25% discounted price for the month of March 2014.
Anu Acharya, CEO of Mapmygenome, said, “Women have a tendency to put their own health on the backburner. We hope that with Gynaecmap™, which is like a once in a lifetime health check, they will be motivated to manage their health better.”
Gynaecologists can gain valuable insights regarding menarche, thyroid function, uterine and ovarian health, fertility treatment, and menopause with Gynaecmap™. It is also the test of choice for recommending early screening for many conditions relevant to women’s health today.
Gynaecmap™ features key functions of women’s wellness – endocrine and reproductive systems, bone health, obesity and lipid levels, lifestyle traits, and cancers. Some of the conditions covered include hypothyroidism, polycystic ovarian syndrome, endometriosis, type 2 diabetes, breast cancer, ovarian cancer, colorectal cancer, and anorexia nervosa. Traits include age at menarche, early menopause, hypertension, body mass index, cholesterol levels, diet pattern, and bone mineral density, among others.
For more information, visit: http://mapmygenome.in/genetictests/gynaecmap.
Founded in August 2012, Mapmygenome is India’s pioneering Genomics Company with a vision to provide “Better Health for Indians using technology.”
They offer personal genomics tests, disease detection kits, brain wellness solutions, and counselling services.
They have a range of personal genomics tests that include Genomepatri™ personal genetic profile featuring 100+ conditions and traits;
Cardiomap™ genetic test for heart disease, diabetes, and other associated lifestyle conditions; Oncomap™ test for cancer; and
Gynaecmap™ test for women. These tests assess not only genetic risks for diseases, traits, and conditions, but also responses to several drugs prescribed for treatment.
Counselling services such as genetic counselling and nutrition counselling add value to the tests. Along with their partners in diagnostics and healthcare, Mapmygenome paves way for customers to receive the best medical attention required to mitigate the risk of diseases.
Mapmygenome also offers brain wellness solutions in India under the portfolio Mapmybrain™.
This includes MyCalmBeat™ to reduce stress, to improve lung function, and to optimize heartbeat. Another innovative product in this range is WebNeuro™ test to screen cognitive strengths and efficiency.
Mapmygenome also offers kits for detecting and typing TB – the SMART Tuberculosis kit for RT-PCR and Spoligotyping kit for PCR. More kits will be launched soon for malaria and other diseases.
For media queries, please contact:
For Immediate Release
Their team at Hyderabad comprises biotechnologists, statisticians, geneticists, bioinformaticians, and genetic counsellors.
Their advisory panel has expert scientists and doctors. In order to enhance this innovative brand and to provide value-added services to
customers, their highly skilled research team works on cutting-edge technologies in various domains.
For more information, visit: www.mapmygenome.in.